Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2
- PMID:16432096
- DOI: 10.1001/archinte.166.2.241
Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2
Abstract
Background: Vitamin K allows for gamma-carboxylation of glutamyl residues, a conversion that activates clotting factors and bone proteins. Vitamin K antagonists such as warfarin inhibit this process. Our goal was to quantify the association between warfarin and osteoporotic fractures in patients with atrial fibrillation.
Methods: This was a retrospective cohort study of Medicare beneficiaries with atrial fibrillation who were hospitalized between March 1998 and April 1999 in all 50 US states. The study outcome was osteoporotic fractures, identified by an International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code for a fracture of the hip, spine, or wrist.
Results: Compared with 7587 patients who were not prescribed warfarin, the adjusted odds ratio (OR) of fracture was 1.25 (95% confidence interval [CI], 1.06-1.48) in 4461 patients prescribed long-term warfarin therapy (> or = 1 year). The association between osteoporotic fracture and long-term warfarin use was significant in men (OR, 1.63; 95% CI, 1.26-2.10) but nonsignificant in women (OR, 1.05; 95% CI, 0.88-1.26). In 1833 patients prescribed warfarin for less than a year, the risk of osteoporotic fracture was not increased significantly (OR, 1.03). Odds ratios (95% CIs) of independent predictors of osteoporotic fractures were as follows: increasing age, 1.63 (1.47-1.80) per decade; high fall risk, 1.78 (1.42-2.21); hyperthyroidism, 1.77 (1.16-2.70); neuropsychiatric disease, 1.51 (1.28-1.78); and alcoholism, 1.50 (1.01-2.24). Factors with a reduced OR (95% CI) included African American race, 0.30 (0.18-0.51); male sex, 0.54 (0.46-0.62); and use of beta-adrenergic antagonists, 0.84 (0.70-1.00).
Conclusions: Long-term use of warfarin was associated with osteoporotic fractures, at least in men with atrial fibrillation. Beta-adrenergic antagonists may protect against osteoporotic fractures.
Comment in
- The association of warfarin use with osteoporotic fracture in elderly patients with atrial fibrillation.Cheng HY.Cheng HY.Arch Intern Med. 2006 Jul 24;166(14):1525; author reply 1525. doi: 10.1001/archinte.166.14.1525-a.Arch Intern Med. 2006.PMID:16864765No abstract available.
Similar articles
- Does statin therapy decrease the risk for bleeding in patients who are receiving warfarin?Douketis JD, Melo M, Bell CM, Mamdani MM.Douketis JD, et al.Am J Med. 2007 Apr;120(4):369.e9-369.e14. doi: 10.1016/j.amjmed.2006.06.008.Am J Med. 2007.PMID:17398234
- 10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program.Hodsman AB, Leslie WD, Tsang JF, Gamble GD.Hodsman AB, et al.Arch Intern Med. 2008 Nov 10;168(20):2261-7. doi: 10.1001/archinte.168.20.2261.Arch Intern Med. 2008.PMID:19001204
- The association of warfarin use with osteoporotic fracture in elderly patients with atrial fibrillation.Cheng HY.Cheng HY.Arch Intern Med. 2006 Jul 24;166(14):1525; author reply 1525. doi: 10.1001/archinte.166.14.1525-a.Arch Intern Med. 2006.PMID:16864765No abstract available.
- Antithrombotic therapy in atrial fibrillation.Garcia DA, Hylek EM.Garcia DA, et al.Clin Geriatr Med. 2006 Feb;22(1):155-66, x. doi: 10.1016/j.cger.2005.09.011.Clin Geriatr Med. 2006.PMID:16377472Review.
- Preventing male osteoporosis: prevalence, risks, diagnosis and imaging tests.Moyad MA.Moyad MA.Urol Clin North Am. 2004 May;31(2):321-30. doi: 10.1016/j.ucl.2004.01.008.Urol Clin North Am. 2004.PMID:15123411Review.
Cited by
- Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system.Triant VA, Brown TT, Lee H, Grinspoon SK.Triant VA, et al.J Clin Endocrinol Metab. 2008 Sep;93(9):3499-504. doi: 10.1210/jc.2008-0828. Epub 2008 Jul 1.J Clin Endocrinol Metab. 2008.PMID:18593764Free PMC article.
- Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis.Namba S, Yamaoka-Tojo M, Hashikata T, Ikeda Y, Kitasato L, Hashimoto T, Shimohama T, Tojo T, Takahira N, Masuda T, Ako J.Namba S, et al.BBA Clin. 2015 Aug 12;4:76-80. doi: 10.1016/j.bbacli.2015.08.002. eCollection 2015 Dec.BBA Clin. 2015.PMID:26674156Free PMC article.
- Anticoagulant use in older persons at risk for falls: therapeutic dilemmas-a clinical review.Mitchell A, Elmasry Y, van Poelgeest E, Welsh TJ.Mitchell A, et al.Eur Geriatr Med. 2023 Aug;14(4):683-696. doi: 10.1007/s41999-023-00811-z. Epub 2023 Jul 1.Eur Geriatr Med. 2023.PMID:37392359Free PMC article.Review.
- Vitamin K and Kidney Transplantation.Fusaro M, Cosmai L, Evenepoel P, Nickolas TL, Cheung AM, Aghi A, Tripepi G, Plebani M, Iervasi G, Vettor R, Zaninotto M, Ravera M, Foramitti M, Giannini S, Sella S, Gallieni M.Fusaro M, et al.Nutrients. 2020 Sep 5;12(9):2717. doi: 10.3390/nu12092717.Nutrients. 2020.PMID:32899501Free PMC article.Review.
- [Drug-induced osteopathies. Drugs, pathogenesis, forms, diagnosis, prevention and therapy].Bartl R, Bartl C, Gradinger R.Bartl R, et al.Orthopade. 2009 Dec;38(12):1245-60; quiz 1261. doi: 10.1007/s00132-009-1436-4.Orthopade. 2009.PMID:19888565German.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous